|
ERLIN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85230000004921E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.844100E-04 |
| Normal-vs-Stage2 |
2.238000E-03 |
| Normal-vs-Stage3 |
2.96519999998246E-07 |
| Normal-vs-Stage4 |
2.379000E-03 |
| Stage1-vs-Stage2 |
3.681800E-01 |
| Stage1-vs-Stage3 |
1.225970E-02 |
| Stage1-vs-Stage4 |
5.512000E-01 |
| Stage2-vs-Stage3 |
4.114800E-01 |
| Stage2-vs-Stage4 |
8.356800E-01 |
| Stage3-vs-Stage4 |
2.513200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.45209999999441E-05 |
| Normal-vs-AfricanAmerican |
6.19800000212223E-09 |
| Normal-vs-Asian |
1.337000E-01 |
| Caucasian-vs-AfricanAmerican |
9.376600E-04 |
| Caucasian-vs-Asian |
9.978200E-01 |
| AfricanAmerican-vs-Asian |
2.049200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.50800000054252E-07 |
| Normal-vs-Female |
7.184200E-04 |
| Male-vs-Female |
1.054400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.035700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.47690000004997E-06 |
| Normal-vs-Age(61-80Yrs) |
6.015199999998E-05 |
| Normal-vs-Age(81-100Yrs) |
1.159520E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.465400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.839600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.542600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.869800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.625200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.323800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.451800E-01 |
| Normal-vs-Grade 2 |
1.338530E-03 |
| Normal-vs-Grade 3 |
9.36280000196632E-08 |
| Normal-vs-Grade 4 |
2.464000E-03 |
| Grade 1-vs-Grade 2 |
1.709840E-02 |
| Grade 1-vs-Grade 3 |
1.944820E-03 |
| Grade 1-vs-Grade 4 |
3.839900E-02 |
| Grade 2-vs-Grade 3 |
1.273840E-02 |
| Grade 2-vs-Grade 4 |
3.738000E-01 |
| Grade 3-vs-Grade 4 |
5.977800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.820500E-02 |
| Normal-vs-ccB subtype |
1.71479999977464E-07 |
| ccA subtype-vs-ccB subtype |
6.27970000000033E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.027100E-04 |
| Normal-vs-N1 |
4.081400E-01 |
| N0-vs-N1 |
8.063600E-01 |
|
|
